18657-117Level 3
HYLENEX Recombinant (Hyaluronidase)
**Product type:** Human Prescription Drug
**Active ingredient:** HYALURONIDASE (HUMAN RECOMBINANT)
**Strength:** 150 [USP'U]/mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** Antares Pharma, Inc.
**Marketing category:** BLA (BLA021859)
**Pharmacologic class:** Endoglycosidase [EPC], Glycoside Hydrolases [CS]
GET
/api/v1/systems/ndc_fda/nodes/18657-117Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.